From Name:
From Email:
To Name:
To Email:

Optional Message:


Radiofrequency ablation, cryoablation and microwave ablation for T1a renal cell carcinoma: A comparative evaluation of therapeutic and renal Function Outcomes

from Journal of Vascular and Interventional Radiology

A retrospective assessment of 297 patients with biopsy-proven RCC treated with image-guided percutaneous thermal ablation was performed between October 2006 and December 2016. Assessments of adverse events, treatment efficacy, and therapeutic outcomes were performed among RF ablation, cryoablation, and MWA. The 2-year disease-free, metastatic-free and cancer-specific survival rates were tabulated. Estimated glomerular filtration rate was used to assess for treatment related changes in renal function. RF ablation, cryoablation and MWA are equivalent at 2 years for treatment of T1a RCC for therapeutic outcome, stability of renal function and low adverse event rate. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063